Lineage Cell Therapeutics Files 8-K
Ticker: LCTX · Form: 8-K · Filed: Jun 23, 2025 · CIK: 876343
| Field | Detail |
|---|---|
| Company | Lineage Cell Therapeutics, Inc. (LCTX) |
| Form Type | 8-K |
| Filed Date | Jun 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: routine-filing, corporate-update
Related Tickers: LCTX
TL;DR
LCTX filed a routine 8-K, no major news.
AI Summary
Lineage Cell Therapeutics, Inc. filed an 8-K on June 23, 2025, reporting on other events and financial statements. The filing does not disclose specific new material events or financial figures but serves as a routine update.
Why It Matters
This 8-K filing indicates routine corporate reporting by Lineage Cell Therapeutics, Inc. It does not appear to contain new material information that would immediately impact the company's stock price.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for other events and financial statements, with no disclosed material changes or new information.
Key Players & Entities
- Lineage Cell Therapeutics, Inc. (company) — Registrant
- 0000950170-25-088738 (filing_id) — Accession Number
- June 23, 2025 (date) — Date of Report
- 2173 Salk Avenue, Suite 200, Carlsbad, California 92008 (address) — Principal Executive Offices
- BIOTIME INC (company) — Former Company Name
FAQ
What is the primary purpose of this 8-K filing for Lineage Cell Therapeutics, Inc.?
The primary purpose of this 8-K filing is to report on 'Other Events' and 'Financial Statements and Exhibits' as of June 23, 2025.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported in this filing is June 23, 2025.
What is the Commission File Number for Lineage Cell Therapeutics, Inc.?
The Commission File Number for Lineage Cell Therapeutics, Inc. is 001-12830.
What was the former name of Lineage Cell Therapeutics, Inc.?
The former name of Lineage Cell Therapeutics, Inc. was BIOTIME INC.
Where are the principal executive offices of Lineage Cell Therapeutics, Inc. located?
The principal executive offices of Lineage Cell Therapeutics, Inc. are located at 2173 Salk Avenue, Suite 200, Carlsbad, California 92008.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 23, 2025 regarding Lineage Cell Therapeutics, Inc. (LCTX).